Welcome to the new morningstar.co.uk! Learn more about the changes and how our new features help your investing success.

AXA Framlington Biotech Fund GBP Z Acc

Performance History31/10/2019
Growth of 1,000 (GBP) Advanced Graph
AXA Framlington Biotech Fund GBP Z Acc
Fund12.3-4.99.7-6.48.6
+/-Cat-1.1-1.0-0.61.50.2
+/-B’mrk-5.91.2-1.4-3.2-0.8
 
Key Stats
NAV
21/11/2019
 GBX 338.70
Day Change 0.06%
Morningstar Category™ Sector Equity Biotechnology
IA (formerly IMA) Sector Specialist
ISIN GB00B784NS11
Fund Size (Mil)
31/10/2019
 GBP 365.27
Share Class Size (Mil)
20/11/2019
 GBP 260.22
Max Initial Charge -
Ongoing Charge
07/08/2019
  0.83%
Investment Objective: AXA Framlington Biotech Fund GBP Z Acc
The aim of this Fund is to provide long-term capital growth. The Fund invests in shares of listed companies, principally in the biotechnology, genomic and medical research industry, which the Manager believes will provide above-average returns. The Fund invests in companies of any size which can be based anywhere in the world, albeit the Fund tends to be biased towards the US as this is where the majority of biotechnology companies are based. The Fund may also invest in other transferable securities and units in collective investment schemes. The Fund may use derivatives for Efficient Portfolio Management. Use may be made of borrowing, cash holdings, hedging and other investment techniques permitted in the applicable Financial Conduct Authority rules.
Returns
Trailing Returns (GBP)21/11/2019
YTD13.81
3 Years Annualised4.05
5 Years Annualised5.73
10 Years Annualised*16.52
12 Month Yield 0.00
Management
Manager Name
Start Date
Linden Thomson
05/07/2012
Dani Saurymper
01/04/2015
Inception Date
16/04/2012
Advertisement
Category Benchmark
Fund BenchmarkMorningstar Benchmark
NASDAQ Biotechnology TR USDNASDAQ Biotechnology TR USD
Target Market
Role In Portfolio
Standalone / CoreNot Specific
ComponentNot Specific
OtherNot Specific
Primary Objective
PreservationNo
GrowthYes
IncomeNot Specific
HedgingNot Specific
OtherNot Specific
Portfolio Profile for  AXA Framlington Biotech Fund GBP Z Acc30/09/2019
Morningstar Style Box®
Equity Style
Asset Allocation
  % Long% Short% Net Assets
Stock95.100.0095.10
Bond0.000.000.00
Property0.000.000.00
Cash4.480.124.36
Other0.560.010.55
Top 5 Regions%
United States83.65
Eurozone5.54
Europe - ex Euro4.12
Japan3.27
Asia - Emerging2.09
Top 5 Sectors%
Healthcare99.74
Industrials0.23
Basic Materials0.02
Financial Services0.00
Real Estate0.00
Top 5 HoldingsSector%
Amgen IncHealthcareHealthcare8.71
Alexion Pharmaceuticals IncHealthcareHealthcare6.62
Gilead Sciences IncHealthcareHealthcare6.59
Biogen IncHealthcareHealthcare6.34
Biomarin Pharmaceutical IncHealthcareHealthcare4.19
AXA Framlington Biotech Fund GBP Z Acc
* This share class has performance data calculated prior to the inception date, 2012-04-16. This is based upon a simulated/extended track record, using the track record of AXA Framlington Biotech R Acc (ISIN: GB0031007254), and is in accordance with Morningstar’s Extended Performance Methodology paper. To find out more about this, click here.
In order to provide consistency across the report data provided by different Asset Managers, the calculated data points presented are generated using Morningstar’s proprietary calculation methodology which is set out in more detail at(https://www.morningstar.com/research/signature)

Audience Confirmation


By clicking 'accept' I acknowledge that this website uses cookies and other technologies to tailor my experience and understand how I and other visitors use our site. See 'Cookie Consent' for more detail.

  • Other Morningstar Websites